<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04556747</url>
  </required_header>
  <id_info>
    <org_study_id>2018-2892</org_study_id>
    <nct_id>NCT04556747</nct_id>
  </id_info>
  <brief_title>FOREVR Peds VR Pilot</brief_title>
  <official_title>Functional Outcome Response to Engaging Virtual Reality in Pediatric Patients (FOREVR Peds Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the feasibility and acceptability of using immersive virtual reality&#xD;
      technologies to impact clinical outcomes (e.g., pain and anxiety) and medication utilization&#xD;
      (e.g., narcotics) in pediatric patients with acute and chronic pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">March 11, 2020</completion_date>
  <primary_completion_date type="Actual">March 11, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of VR-distraction on anxiety</measure>
    <time_frame>Before 10 minute VR session.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Distraction on anxiety</measure>
    <time_frame>Immediately after 10 minute VR session.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Distraction on anxiety</measure>
    <time_frame>15 minutes after 10 minute VR session.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Distraction on anxiety</measure>
    <time_frame>30 minutes after 10 minute VR session.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Distraction on pain</measure>
    <time_frame>Before 10 minute VR session.</time_frame>
    <description>Pain scores will be collected. Pain will be rated using a numerical rating scale. Pain will be rated from 0 - 10. 0 meaning no pain 10 being severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Distraction on pain</measure>
    <time_frame>Immediately after 10 minute VR session.</time_frame>
    <description>Pain scores will be collected. Pain will be rated using a numerical rating scale. Pain will be rated from 0 - 10. 0 meaning no pain 10 being severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Distraction on pain</measure>
    <time_frame>15 minutes after 10 minute VR session.</time_frame>
    <description>Pain scores will be collected. Pain will be rated using a numerical rating scale. Pain will be rated from 0 - 10. 0 meaning no pain 10 being severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Distraction on pain</measure>
    <time_frame>30 minutes after 10 minute VR session.</time_frame>
    <description>Pain scores will be collected. Pain will be rated using a numerical rating scale. Pain will be rated from 0 - 10. 0 meaning no pain 10 being severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Biofeedback on anxiety</measure>
    <time_frame>Before 10 minute VR session.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Biofeedback on anxiety</measure>
    <time_frame>Immediately after 10 minute VR session.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Biofeedback on anxiety</measure>
    <time_frame>15 minutes after 10 minute VR session.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Biofeedback on anxiety</measure>
    <time_frame>30 minutes after 10 minute VR session.</time_frame>
    <description>Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Biofeedback on pain</measure>
    <time_frame>Before 10 minute VR session</time_frame>
    <description>Pain scores will be collected. Pain will be rated using a numerical rating scale. Pain will be rated from 0 - 10. 0 meaning no pain 10 being severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Biofeedback on pain</measure>
    <time_frame>Immediately after 10 minute VR session</time_frame>
    <description>Pain scores will be collected. Pain will be rated using a numerical rating scale. Pain will be rated from 0 - 10. 0 meaning no pain 10 being severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Biofeedback on pain</measure>
    <time_frame>15 minutes after 10 minute VR session</time_frame>
    <description>Pain scores will be collected. Pain will be rated using a numerical rating scale. Pain will be rated from 0 - 10. 0 meaning no pain 10 being severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of VR-Biofeedback on pain</measure>
    <time_frame>30 minutes after 10 minute VR session</time_frame>
    <description>Pain scores will be collected. Pain will be rated using a numerical rating scale. Pain will be rated from 0 - 10. 0 meaning no pain 10 being severe pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Role of anxiety on changes in pain</measure>
    <time_frame>One time prior to study visit</time_frame>
    <description>Participants will complete a questionnaire regarding anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Role of pain catastrophizing</measure>
    <time_frame>One time prior to study visit</time_frame>
    <description>Participants will complete a questionnaire regarding pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">111</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Pain</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>VR - Distraction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>VR - Biofeedback</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VR - Distraction</intervention_name>
    <description>Participants will be instructed to use any application.</description>
    <arm_group_label>VR - Distraction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VR - Biofeedback</intervention_name>
    <description>Participants will be instructed to use the Mindful Aurora application.</description>
    <arm_group_label>VR - Biofeedback</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ages 7to 21 years&#xD;
&#xD;
          -  Able to read, understand, and speak English&#xD;
&#xD;
          -  Patients in the immediate postoperative period with significant pain being followed by&#xD;
             the Acute Pain Service (acute postoperative pain cohort); patients presenting in Same&#xD;
             Day Surgery for peripheral IV placement or patients in the CBDI clinic presenting for&#xD;
             peripheral IV placement or Port accessing (vascular access cohort); or patients&#xD;
             admitted to CCHMC on the Medical Pain Service (chronic pain cohort), or sickle cell&#xD;
             patients not on the MPS list.&#xD;
&#xD;
          -  Patients who have undergone bone marrow transplantation or receiving chemotherapy&#xD;
             experiencing pain from mucositis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Outside the age range (&lt; 7 or &gt; 21 years)&#xD;
&#xD;
          -  History of developmental delays, uncontrolled psychiatric conditions, or neurological&#xD;
             conditions (especially epilepsy and/or significant motion sickness/nausea/vomiting)&#xD;
&#xD;
          -  History of vertigo, dizziness, and/or seizure disorder&#xD;
&#xD;
          -  Conditions that would preclude the application of the VR glasses, such as surgeries of&#xD;
             the head and neck&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vanessa Olbrecht, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cincinnati Childrens Hospital Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cincinnati Childrens Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 15, 2020</study_first_submitted>
  <study_first_submitted_qc>September 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2020</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>This information will be made available upon request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Data will become available upon publication. All data will be deidentified.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

